Knowing the demerits of the transrectal ultrasound guided biopsy has led to a shift in the general techniques and technology of the prostate biopsy. In addition, the advances in magnetic resonance imaging (MRI) sensitivity and the evidence from the PROMIS trial about its ability to detect clinically significant tumours encourage urologists and industry to implement MRI-guided targeted biopsy. However, the science is still looking how to improve safety and increase its cancer detection rate (CDR).
Translational andrology and urology. 2020 Jun [Epub]
Mohamed Essam Noureldin, Martin J Connor, Nicholas Boxall, Saiful Miah, Taimur Shah, Jochen Walz
Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK., Department of Urology, Cambridge University Hospitals, Cambridge, UK., Department of Urology, Institut Paoli-Calmettes Cancer Centre, Marseille, France.